메뉴 건너뛰기




Volumn 35, Issue 24, 2016, Pages 3103-3113

Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CABERGOLINE; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; FENOLDOPAM; LIFICIGUAT; TADALAFIL; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

EID: 84975106364     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.369     Document Type: Article
Times cited : (80)

References (48)
  • 1
    • 0036654027 scopus 로고    scopus 로고
    • The peripheral dopaminergic system: Morphological analysis, functional and clinical applications
    • Amenta F, Ricci A, Tayebati SK, Zaccheo D. The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 2002; 107: 145-167.
    • (2002) Ital J Anat Embryol , vol.107 , pp. 145-167
    • Amenta, F.1    Ricci, A.2    Tayebati, S.K.3    Zaccheo, D.4
  • 2
    • 78649821142 scopus 로고    scopus 로고
    • Minireview: New roles for peripheral dopamine on metabolic control and tumor growth: Let's seek the balance
    • Rubi B, Maechler P. Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance. Endocrinology 2010; 151: 5570-5581.
    • (2010) Endocrinology , vol.151 , pp. 5570-5581
    • Rubi, B.1    Maechler, P.2
  • 4
    • 33644829284 scopus 로고    scopus 로고
    • Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, function in wildtype and knock-out mice
    • Li ZS, Schmauss C, Cuenca A, Ratcliffe E, Gershon MD. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, function in wildtype and knock-out mice. J Neurosci 2006; 26: 2798-2807.
    • (2006) J Neurosci , vol.26 , pp. 2798-2807
    • Li, Z.S.1    Schmauss, C.2    Cuenca, A.3    Ratcliffe, E.4    Gershon, M.D.5
  • 7
    • 0033848928 scopus 로고    scopus 로고
    • Coupling of dopamine receptor subtypes to multiple and diverse G proteins
    • Sidhu A, Niznik HB. Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int J Dev Neurosci 2000; 18: 669-677.
    • (2000) Int J Dev Neurosci , vol.18 , pp. 669-677
    • Sidhu, A.1    Niznik, H.B.2
  • 8
    • 79952032110 scopus 로고    scopus 로고
    • The physiology, signaling, pharmacology of dopamine receptors
    • Beaulieu JM, Gainetdinov RR. The physiology, signaling, pharmacology of dopamine receptors. Pharmacol Rev 2011; 63: 182-217.
    • (2011) Pharmacol Rev , vol.63 , pp. 182-217
    • Beaulieu, J.M.1    Gainetdinov, R.R.2
  • 9
    • 84873413896 scopus 로고    scopus 로고
    • Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission
    • Arcangeli S, Tozzi A, Tantucci M, Spaccatini C, de Iure A, Costa C et al. Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. J Cereb Blood Flow Metab 2013; 33: 278-286.
    • (2013) J Cereb Blood Flow Metab , vol.33 , pp. 278-286
    • Arcangeli, S.1    Tozzi, A.2    Tantucci, M.3    Spaccatini, C.4    De Iure, A.5    Costa, C.6
  • 10
    • 77952944361 scopus 로고    scopus 로고
    • Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons
    • Lin DT, Fretier P, Jiang C, Vincent SR. Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons. Synapse 2010; 64: 460-466.
    • (2010) Synapse , vol.64 , pp. 460-466
    • Lin, D.T.1    Fretier, P.2    Jiang, C.3    Vincent, S.R.4
  • 11
    • 76749172150 scopus 로고    scopus 로고
    • The d5 dopamine receptor mediates large-conductance, calcium-and voltage-activated potassium channel activation in human coronary artery smooth muscle cells
    • Natarajan A, Han G, Chen SY, Yu P, White R, Jose P. The d5 dopamine receptor mediates large-conductance, calcium-and voltage-activated potassium channel activation in human coronary artery smooth muscle cells. J Pharmacol Exp Ther 2010; 332: 640-649.
    • (2010) J Pharmacol Exp Ther , vol.332 , pp. 640-649
    • Natarajan, A.1    Han, G.2    Chen, S.Y.3    Yu, P.4    White, R.5    Jose, P.6
  • 12
    • 84903709050 scopus 로고    scopus 로고
    • Membrane guanylate cyclase, a multimodal transduction machine: History, present, future directions
    • Sharma RK, Duda T. Membrane guanylate cyclase, a multimodal transduction machine: history, present, future directions. Front Mol Neurosci 2014; 7: 56.
    • (2014) Front Mol Neurosci , vol.7 , pp. 56
    • Sharma, R.K.1    Duda, T.2
  • 13
    • 33748312096 scopus 로고    scopus 로고
    • NOindependent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential
    • Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, Stasch JP. NOindependent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 2006; 5: 755-768.
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 755-768
    • Evgenov, O.V.1    Pacher, P.2    Schmidt, P.M.3    Haskó, G.4    Schmidt, H.H.5    Stasch, J.P.6
  • 15
    • 33748745120 scopus 로고    scopus 로고
    • Phosphodiesterase 5 inhibitors-drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles
    • Supuran CT, Mastrolorenzo A, Barbaro G, Scozzafava A. Phosphodiesterase 5 inhibitors-drug design and differentiation based on selectivity, pharmacokinetic and efficacy profiles. Curr Pharm Des 2006; 12: 3459-3465.
    • (2006) Curr Pharm des , vol.12 , pp. 3459-3465
    • Supuran, C.T.1    Mastrolorenzo, A.2    Barbaro, G.3    Scozzafava, A.4
  • 16
    • 33847644982 scopus 로고    scopus 로고
    • The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels
    • Zhu B, Strada SJ. The novel functions of cGMP-specific phosphodiesterase 5 and its inhibitors in carcinoma cells and pulmonary/cardiovascular vessels. Curr Top Med Chem 2007; 7: 437-454.
    • (2007) Curr Top Med Chem , vol.7 , pp. 437-454
    • Zhu, B.1    Strada, S.J.2
  • 17
    • 33750317276 scopus 로고    scopus 로고
    • Tadalafil, a longacting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke
    • Zhang L, Zhang Z, Zhang RL, Cui Y, LaPointe MC, Silver B et al. Tadalafil, a longacting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res 2006; 1118: 192-198.
    • (2006) Brain Res , vol.1118 , pp. 192-198
    • Zhang, L.1    Zhang, Z.2    Zhang, R.L.3    Cui, Y.4    LaPointe, M.C.5    Silver, B.6
  • 18
    • 84886640594 scopus 로고
    • Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum
    • Flaim KE, Gessner GW, Crooke ST, Sarau HM, Weinstock J. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum. Life Sci 1985; 36: 1427-1436.
    • (1985) Life Sci , vol.36 , pp. 1427-1436
    • Flaim, K.E.1    Gessner, G.W.2    Crooke, S.T.3    Sarau, H.M.4    Weinstock, J.5
  • 19
    • 0035936042 scopus 로고    scopus 로고
    • Fenoldopam: A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension
    • Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001; 345: 1548-1557.
    • (2001) N Engl J Med , vol.345 , pp. 1548-1557
    • Murphy, M.B.1    Murray, C.2    Shorten, G.D.3
  • 20
    • 0034051167 scopus 로고    scopus 로고
    • In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist
    • Ng SS, Pang CC. In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist. Br J Pharmacol 2000; 129: 853-858.
    • (2000) Br J Pharmacol , vol.129 , pp. 853-858
    • Ng, S.S.1    Pang, C.C.2
  • 21
    • 0023899110 scopus 로고
    • Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients
    • Weber RR, McCoy CE, Ziemniak JA, Frederickson ED, Goldberg LI, Murphy MB. Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. Br J Clin Pharmacol 1988; 25: 17-21.
    • (1988) Br J Clin Pharmacol , vol.25 , pp. 17-21
    • Weber, R.R.1    McCoy, C.E.2    Ziemniak, J.A.3    Frederickson, E.D.4    Goldberg, L.I.5    Murphy, M.B.6
  • 22
    • 60849115247 scopus 로고    scopus 로고
    • Should we be cautious on the use of commercially available antibodies to dopamine receptors?
    • Bodei S, Arrighi N, Spano P, Sigala S. Should we be cautious on the use of commercially available antibodies to dopamine receptors? Naunyn Schmiedebergs Arch Pharmacol 2009; 379: 413-415.
    • (2009) Naunyn Schmiedebergs Arch Pharmacol , vol.379 , pp. 413-415
    • Bodei, S.1    Arrighi, N.2    Spano, P.3    Sigala, S.4
  • 25
    • 84861060154 scopus 로고    scopus 로고
    • Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders
    • Shen LH, Liao MH, Tseng YC. Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol 2012;2012: 259-349.
    • (2012) J Biomed Biotechnol , vol.2012 , pp. 259-349
    • Shen, L.H.1    Liao, M.H.2    Tseng, Y.C.3
  • 26
    • 64549145847 scopus 로고    scopus 로고
    • Role of positron-emission tomography scan in the diagnosis and management of breast cancer
    • Almubarak M, Osman S, Marano G, Abraham J. Role of positron-emission tomography scan in the diagnosis and management of breast cancer. Oncology (Williston Park) 2009; 23: 255-261.
    • (2009) Oncology (Williston Park) , vol.23 , pp. 255-261
    • Almubarak, M.1    Osman, S.2    Marano, G.3    Abraham, J.4
  • 27
    • 84892592536 scopus 로고    scopus 로고
    • Riociguat: First global approval
    • Conole D, Scott LJ. Riociguat: first global approval. Drugs 2013; 73: 1967-1975.
    • (2013) Drugs , vol.73 , pp. 1967-1975
    • Conole, D.1    Scott, L.J.2
  • 29
    • 84861995326 scopus 로고    scopus 로고
    • Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells
    • Sachlos E, Risuenõ RM, Laronde S, Shapovalova Z, Lee JH, Russell J et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 2012; 149: 1284-1297.
    • (2012) Cell , vol.149 , pp. 1284-1297
    • Sachlos, E.1    Risuenõ, R.M.2    Laronde, S.3    Shapovalova, Z.4    Lee, J.H.5    Russell, J.6
  • 31
    • 35148895156 scopus 로고    scopus 로고
    • Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line
    • Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 2007; 53: 724-732.
    • (2007) Neuropharmacology , vol.53 , pp. 724-732
    • Zhao, D.L.1    Zou, L.B.2    Lin, S.3    Shi, J.G.4    Zhu, H.B.5
  • 33
    • 42249112993 scopus 로고    scopus 로고
    • Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models
    • Sarkar C, Chakroborty D, Chowdhury UR, Dasgupta PS, Basu S. Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models. Clin Cancer Res 2008; 14: 2502-2510.
    • (2008) Clin Cancer Res , vol.14 , pp. 2502-2510
    • Sarkar, C.1    Chakroborty, D.2    Chowdhury, U.R.3    Dasgupta, P.S.4    Basu, S.5
  • 34
    • 0029018929 scopus 로고
    • The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells
    • Johnson DE, Ochieng J, Evans SL. The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells. Anticancer Drugs 1995; 6: 471-474.
    • (1995) Anticancer Drugs , vol.6 , pp. 471-474
    • Johnson, D.E.1    Ochieng, J.2    Evans, S.L.3
  • 35
    • 72649087941 scopus 로고    scopus 로고
    • Heterodimerization of dopamine receptors: New insights into functional and therapeutic significance
    • Maggio R, Aloisi G, Silvano E, Rossi M, Millan MJ. Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance. Parkinsonism Relat Disord 2009; 15: S2-S7.
    • (2009) Parkinsonism Relat Disord , vol.15 , pp. S2-S7
    • Maggio, R.1    Aloisi, G.2    Silvano, E.3    Rossi, M.4    Millan, M.J.5
  • 38
    • 34447618279 scopus 로고    scopus 로고
    • Human sulfatases: A structural perspective to catalysis
    • Ghosh D. Human sulfatases: a structural perspective to catalysis. Cell Mol Life Sci 2007; 64: 2013-2022.
    • (2007) Cell Mol Life Sci , vol.64 , pp. 2013-2022
    • Ghosh, D.1
  • 39
    • 0033621476 scopus 로고    scopus 로고
    • X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity
    • Dajani R, Cleasby A, Neu M, Wonacott AJ, Jhoti H, Hood AM et al. X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J Biol Chem 1999; 274: 37862-37868.
    • (1999) J Biol Chem , vol.274 , pp. 37862-37868
    • Dajani, R.1    Cleasby, A.2    Neu, M.3    Wonacott, A.J.4    Jhoti, H.5    Hood, A.M.6
  • 40
    • 34250156365 scopus 로고    scopus 로고
    • CAMP and cGMP signaling cross-talk: Role of phosphodiesterases and implications for cardiac pathophysiology
    • Zaccolo M, Movsesian MA. cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. Circ Res 2007; 100: 1569-1578.
    • (2007) Circ Res , vol.100 , pp. 1569-1578
    • Zaccolo, M.1    Movsesian, M.A.2
  • 41
    • 72049113572 scopus 로고    scopus 로고
    • Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity
    • Hoque KE, Indorkar RP, Sammut S, West AR. Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity. Psychopharmacology (Berl) 2010; 207: 571-581.
    • (2010) Psychopharmacology (Berl) , vol.207 , pp. 571-581
    • Hoque, K.E.1    Indorkar, R.P.2    Sammut, S.3    West, A.R.4
  • 42
    • 33244477604 scopus 로고    scopus 로고
    • Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism
    • Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, West AR. Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuropsychopharmacology 2006; 31: 493-505.
    • (2006) Neuropsychopharmacology , vol.31 , pp. 493-505
    • Sammut, S.1    Dec, A.2    Mitchell, D.3    Linardakis, J.4    Ortiguela, M.5    West, A.R.6
  • 45
    • 4143067127 scopus 로고    scopus 로고
    • Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis
    • Basu S, Sarkar C, Chakroborty D, Nagy J, Mitra RB, Dasgupta PS et al. Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis. Cancer Res 2004; 64: 5551-5555.
    • (2004) Cancer Res , vol.64 , pp. 5551-5555
    • Basu, S.1    Sarkar, C.2    Chakroborty, D.3    Nagy, J.4    Mitra, R.B.5    Dasgupta, P.S.6
  • 46
    • 0035026748 scopus 로고    scopus 로고
    • The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
    • Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001; 7: 569-574.
    • (2001) Nat Med , vol.7 , pp. 569-574
    • Basu, S.1    Nagy, J.A.2    Pal, S.3    Vasile, E.4    Eckelhoefer, I.A.5    Bliss, V.S.6
  • 48
    • 4744348385 scopus 로고    scopus 로고
    • Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, focal adhesion kinase in endothelial cells
    • Sarkar C, Chakroborty D, Mitra RB, Banerjee S, Dasgupta PS, Basu S. Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, focal adhesion kinase in endothelial cells. Am J Physiol Heart Circ Physiol 2004; 287: H1554-H1560.
    • (2004) Am J Physiol Heart Circ Physiol , vol.287 , pp. H1554-H1560
    • Sarkar, C.1    Chakroborty, D.2    Mitra, R.B.3    Banerjee, S.4    Dasgupta, P.S.5    Basu, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.